145 related articles for article (PubMed ID: 30044012)
1. RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes.
Bae HC; Jeong SH; Kim JH; Lee H; Ryu WI; Kim MG; Son ED; Lee TR; Son SW
Exp Dermatol; 2018 Oct; 27(10):1126-1133. PubMed ID: 30044012
[TBL] [Abstract][Full Text] [Related]
2. Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes.
Tohyama M; Shirakata Y; Hanakawa Y; Dai X; Shiraishi K; Murakami M; Miyawaki S; Mori H; Utsunomiya R; Masuda K; Hashimoto K; Sayama K
Eur J Immunol; 2018 Jan; 48(1):168-179. PubMed ID: 28901004
[TBL] [Abstract][Full Text] [Related]
3. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
Andrés RM; Hald A; Johansen C; Kragballe K; Iversen L
Exp Dermatol; 2013 May; 22(5):323-8. PubMed ID: 23614738
[TBL] [Abstract][Full Text] [Related]
4. IL-17F regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Ljungberg C; Boye Kjellerup R; Iversen L; Johansen C
Exp Dermatol; 2017 Mar; 26(3):234-241. PubMed ID: 27576147
[TBL] [Abstract][Full Text] [Related]
5. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
6. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.
Tohyama M; Hanakawa Y; Shirakata Y; Dai X; Yang L; Hirakawa S; Tokumaru S; Okazaki H; Sayama K; Hashimoto K
Eur J Immunol; 2009 Oct; 39(10):2779-88. PubMed ID: 19731362
[TBL] [Abstract][Full Text] [Related]
7. Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.
Kanda N; Shibata S; Tada Y; Nashiro K; Tamaki K; Watanabe S
Eur J Immunol; 2009 Apr; 39(4):996-1006. PubMed ID: 19350575
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
9. The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.
Furue K; Ito T; Tanaka Y; Hashimoto-Hachiya A; Takemura M; Murata M; Kido-Nakahara M; Tsuji G; Nakahara T; Furue M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936670
[TBL] [Abstract][Full Text] [Related]
10. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis.
Li H; Li H; Huo R; Wu P; Shen Z; Xu H; Shen B; Li N
J Dermatol Sci; 2017 Oct; 88(1):46-56. PubMed ID: 28602508
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NF-kappaB activity and keratinocyte differentiation by the RIP4 protein: implications for cutaneous wound repair.
Adams S; Pankow S; Werner S; Munz B
J Invest Dermatol; 2007 Mar; 127(3):538-44. PubMed ID: 17039240
[TBL] [Abstract][Full Text] [Related]
12. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes.
Kanda N; Hau CS; Tada Y; Tatsuta A; Sato S; Watanabe S
Endocrinology; 2011 Aug; 152(8):3155-64. PubMed ID: 21673103
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-17 on receptor-interacting protein 4 expression and keratinocyte proliferation.
Jia K; Zhang Y; Ma W; Zhang X; Sun Q
Exp Ther Med; 2015 Jul; 10(1):374-378. PubMed ID: 26170965
[TBL] [Abstract][Full Text] [Related]
14. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.
Wu NL; Huang DY; Tsou HN; Lin YC; Lin WW
J Invest Dermatol; 2015 Feb; 135(2):490-498. PubMed ID: 25202827
[TBL] [Abstract][Full Text] [Related]
15. IL-22-induced miR-122-5p promotes keratinocyte proliferation by targeting Sprouty2.
Jiang M; Ma W; Gao Y; Jia K; Zhang Y; Liu H; Sun Q
Exp Dermatol; 2017 Apr; 26(4):368-374. PubMed ID: 27943426
[TBL] [Abstract][Full Text] [Related]
16. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M upregulates Livin to promote keratinocyte proliferation and survival via ERK and STAT3 signalling pathways.
Wang H; Lei L; Hu J; Li Y
Exp Physiol; 2020 Jul; 105(7):1151-1158. PubMed ID: 32359099
[TBL] [Abstract][Full Text] [Related]
18. hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes.
Chowdhari S; Saini N
J Cell Physiol; 2014 Nov; 229(11):1630-8. PubMed ID: 24610393
[TBL] [Abstract][Full Text] [Related]
19. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
[TBL] [Abstract][Full Text] [Related]
20. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.
Sestito R; Madonna S; Scarponi C; Cianfarani F; Failla CM; Cavani A; Girolomoni G; Albanesi C
FASEB J; 2011 Mar; 25(3):916-27. PubMed ID: 21098725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
